An observational study investigating efficacy and safety of the combination of rilpivirine and dolutegravir in patients with HIV-1 infection in clinical practice

Trial Profile

An observational study investigating efficacy and safety of the combination of rilpivirine and dolutegravir in patients with HIV-1 infection in clinical practice

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Dec 2016

At a glance

  • Drugs Dolutegravir (Primary) ; Rilpivirine (Primary)
  • Indications HIV-1 infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 30 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top